1. Home
  2. CYPH vs EFR Comparison

CYPH vs EFR Comparison

Compare CYPH & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies Inc.

N/A

Current Price

$2.00

Market Cap

321.1M

Sector

Health Care

ML Signal

N/A

Logo Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

EFR

Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

N/A

Current Price

$10.26

Market Cap

305.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CYPH
EFR
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
321.1M
305.6M
IPO Year
2019
2003

Fundamental Metrics

Financial Performance
Metric
CYPH
EFR
Price
$2.00
$10.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 13.3M
112.4K
Earning Date
11-16-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 103.87
N/A
EPS
N/A
★ N/A
Revenue
★ $1,500,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$408.92
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.49
$9.94
52 Week High
$4.19
$11.36

Technical Indicators

Market Signals
Indicator
CYPH
EFR
Relative Strength Index (RSI) 40.45 52.08
Support Level $0.65 $10.17
Resistance Level $3.42 $10.65
Average True Range (ATR) 0.39 0.11
MACD -0.11 0.02
Stochastic Oscillator 7.69 71.11

Price Performance

Historical Comparison
CYPH
EFR

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest

Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.

Share on Social Networks: